Provectus Biopharmaceuticals Inc., of Knoxville, Tenn., said the protocol for its phase II study of the mechanism of action of PH-10 in psoriasis is now available on www.clinicaltrials.gov. Read More
Ariad Pharmaceuticals Inc., of Cambridge, Mass., and Otsuka Pharmaceutical Co. Ltd., of Tokyo, said they entered an agreement for Otsuka to commercialize Ariad's Iclusig (ponatinib) in Japan and nine other Asian countries and to fund future clinical trials in those regions. Read More
Lion Biotechnologies Inc., of Los Angeles, said it closed its underwritten offering of 6 million shares priced at $5.75 apiece, including 782,608 shares to cover the full overallotment option. Gross proceeds totaled $34.5 million. Read More
The Department of Justice (DoJ) filed a civil False Claims Act complaint, in conjunction with two whistleblower actions, against Omnicare Inc., of Crystal, Minn., alleging that the pharmaceuticals provider solicited and received millions of dollars in kickbacks from Abbott, of Abbott Park, Ill., in exchange for purchasing and recommending anticonvulsant drug Depakote (valproic acid) for controlling dementia patients in nursing homes it serviced. Read More
SHANGHAI – Eddingpharm Co. Ltd. will develop and commercialize Cardiome Pharma Corp.'s atrial fibrillation drug, Brinavess (vernakalant), paying $1 million up front for the Greater China rights with potential for the Vancouver, British Columbia-based Cardiome to receive $3 million more in regulatory milestone payments. Read More
BOGOTA, Colombia – The National Council of Genetic Engineering of Cuba (CIGB) and the National Council of Technical and Scientific Researches of Argentina (Conicet) have agreed to team up for the development of new biotech products. Read More
BOGOTA, Colombia – The world is still reeling from President Barack Obama's historic announcement that the U.S. and Cuba would re-establish diplomatic relations that had been frozen since Washington imposed the 1960 embargo on the Caribbean island. Read More
LONDON – Scientists reported that they have found an ideal drug target that could lead to a treatment for lung cancer. The study, by an international team of researchers, identified a molecule that is found in lung cancer cells but not in normal lung tissue. Read More
SHANGHAI – Sciclone Pharmaceuticals Inc. has had a pretty good year. The company continues to grow in the double digits and has hit revenue expectations for several quarters, helping to push stock prices to a rosy $8 to $9 range from a depressed low of $4 last year. Read More
As the smoke clears from the resolution of Vanda Pharmaceuticals Inc.'s tussle with Novartis AG over the approved but weak-selling schizophrenia drug Fanapt (iloperidone), investors are turning their eyes toward AQW051, the phase II alpha-7 nicotinic acetylcholine receptor partial agonist that Vanda gained – along with a $25 million equity investment – in its settlement with the pharma giant. Read More
Galderma Laboratories L.P., of Fort Worth, Texas, said the FDA approved Soolantra (ivermectin) Cream, 1 percent, for the once-daily topical treatment of inflammatory lesions, or bumps and pimples, of rosacea. Read More
